Asia Pacific Neurorehabilitation Devices Market Forecast to 2031- Regional Analysis - by Product Type, Application, and End User

Description

List of Tables

The Asia Pacific neurorehabilitation devices market was valued at US$ 445.40 million in 2023 and is expected to reach US$ 1,399.71 million by 2031; it is estimated to register a CAGR of 15.4% from 2023 to 2031.

Strategic Initiatives by Market Players Boost Asia Pacific Neurorehabilitation Devices Market

Strategic initiatives taken by market players, such as mergers, acquisitions, partnerships, and collaborations, are likely to accelerate innovation, develop expertise, and expand market reach.

In April 2022, Blackrock Neurotech partnered with Phantom Neuro, a neurotech startup, to carry out R&D for Phantom Neuro's patent-pending Phantom X system, which offers patients highly accurate, almost real-time control of current and next-generation assistive devices, such as prosthetics and exoskeletons. This R&D partnership allows Phantom to use Blackrock's decades of experience in neurotechnology and develop biocompatible implantable sensors to complement and bolster the Phantom X platform.

In December 2022, Ekso Bionics-a leader in exoskeleton technology for medical use-announced the acquisition of the Human Motion and Control ("HMC") Business Unit from Parker Hannifin Corporation. This acquisition will enhance Ekso's product portfolio and improve its strategic relationships with commercial and research partners such as Vanderbilt University. The partnership with Vanderbilt is expected to enhance its research capabilities and product development.

Thus, the strategic initiatives taken by the market players are likely to create lucrative opportunities for the neurorehabilitation market in the near future.

Asia Pacific Neurorehabilitation Devices Market Overview

The increasing incidences of neurological diseases coupled with the aging population drive the demand for effective rehabilitation solutions. Parkinson's disease (PD) is a common neurodegenerative disease in the country. According to China Daily, there were ~4 million patients suffering from PD in China as of February 2023, and ~1.7% of people over 65 years have been diagnosed with the disease. Neurorehabilitation devices are crucial in managing the symptoms of Parkinson's disease, which is characterized by both motor and non-motor challenges that significantly affect patients' quality of life. These devices help enhance motor function, improve gait and balance, and facilitate daily activities in patients.

Technological developments in robotics and strategic efforts by companies are expected to hold potential growth opportunities for the market in China during the forecast period.

Asia Pacific Neurorehabilitation Devices Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Neurorehabilitation Devices Market Segmentation

The Asia Pacific neurorehabilitation devices market is categorized into product type, application, end user, and country.

By product type, the Asia Pacific neurorehabilitation devices market is segmented into neurorobotic system, brain computer interface, non-invasive stimulators, and wearable devices. The brain computer interface segment held the largest share of the Asia Pacific neurorehabilitation devices market share in 2023.

In terms of application, the Asia Pacific neurorehabilitation devices market is segmented into stroke, traumatic brain injury, spinal cord injury, Parkinson's disease, cerebral palsy, and others. The stroke segment held the largest share of the Asia Pacific neurorehabilitation devices market share in 2023.

By end user, the Asia Pacific neurorehabilitation devices market is segmented into rehabilitation centers, hospitals & clinics, and home care. The hospitals & clinics segment held the largest share of the Asia Pacific neurorehabilitation devices market share in 2023.

Based on country, the Asia Pacific neurorehabilitation devices market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China segment held the largest share of Asia Pacific neurorehabilitation devices Market in 2023.

Abbott Laboratories; BIONIK; BioXtreme Ltd; Blackrock Microsystems Inc; Ekso Bionics Holdings Inc; EMOTIV; Hocoma AG; Medtronic Plc; Renishaw Plc; and Tyromotion GmbH are some of the leading companies operating in the Asia Pacific neurorehabilitation devices market.

Product Code: BMIRE00031350

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Neurorehabilitation Devices Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Average Selling Price

5. Asia Pacific Neurorehabilitation Devices Market - Key Market Dynamics

5.1 Asia Pacific Neurorehabilitation Devices Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Neurological Diseases
- 5.2.2 Growing Number of Clinical Studies on Neurorehabilitation Devices
5.3 Market Restraints
- 5.3.1 High Costs Associated with Neurorehabilitation Devices
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
- 5.5.1 Technological Advancements
5.6 Impact of Drivers and Restraints:

6. Asia Pacific Neurorehabilitation Devices Market - Analysis

6.1 Asia Pacific Neurorehabilitation Devices Market Revenue (US$ Million), 2021-2031
6.2 Asia Pacific Neurorehabilitation Devices Market Forecast Analysis

7. Asia Pacific Neurorehabilitation Devices Market Analysis - by Product Type

7.1 Neurorobotic System
- 7.1.1 Overview
- 7.1.2 Neurorobotic System: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Brain Computer Interface
- 7.2.1 Overview
- 7.2.2 Brain Computer Interface: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Non-invasive Stimulators
- 7.3.1 Overview
- 7.3.2 Non-invasive Stimulators: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Wearable Devices
- 7.4.1 Overview
- 7.4.2 Wearable Devices: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Neurorehabilitation Devices Market Analysis - by Application

8.1 Stroke
- 8.1.1 Overview
- 8.1.2 Stroke: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Traumatic Brain Injury
- 8.2.1 Overview
- 8.2.2 Traumatic Brain Injury: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Spinal Cord Injury
- 8.3.1 Overview
- 8.3.2 Spinal Cord Injury: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Parkinson's Disease
- 8.4.1 Overview
- 8.4.2 Parkinson's Disease: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Cerebral Palsy
- 8.5.1 Overview
- 8.5.2 Cerebral Palsy: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Neurorehabilitation Devices Market Analysis - by End User

9.1 Rehabilitation Centers
- 9.1.1 Overview
- 9.1.2 Rehabilitation Centers: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Hospitals and Clinics: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Home Care
- 9.3.1 Overview
- 9.3.2 Home Care: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Neurorehabilitation Devices Market - Country Analysis

10.1 Asia Pacific
- 10.1.1 Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 China: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 China: Asia Pacific Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.2.2 China: Asia Pacific Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.2.3 China: Asia Pacific Neurorehabilitation Devices Market Share - by End User
  - 10.1.1.3 Japan: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 Japan: Asia Pacific Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.3.2 Japan: Asia Pacific Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.3.3 Japan: Asia Pacific Neurorehabilitation Devices Market Share - by End User
  - 10.1.1.4 India: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 India: Asia Pacific Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.4.2 India: Asia Pacific Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.4.3 India: Asia Pacific Neurorehabilitation Devices Market Share - by End User
  - 10.1.1.5 Australia: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.5.1 Australia: Asia Pacific Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.5.2 Australia: Asia Pacific Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.5.3 Australia: Asia Pacific Neurorehabilitation Devices Market Share - by End User
  - 10.1.1.6 South Korea: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.6.1 South Korea: Asia Pacific Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.6.2 South Korea: Asia Pacific Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.6.3 South Korea: Asia Pacific Neurorehabilitation Devices Market Share - by End User
  - 10.1.1.7 Rest of APAC: Asia Pacific Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.7.1 Rest of APAC: Asia Pacific Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.7.2 Rest of APAC: Asia Pacific Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.7.3 Rest of APAC: Asia Pacific Neurorehabilitation Devices Market Share - by End User

11. Industry Landscape

11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations

12. Company Profiles

12.1 Blackrock Microsystems Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Hocoma AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Medtronic Plc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Tyromotion GmbH
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Ekso Bionics Holdings Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 BIONIK
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Abbott Laboratories
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Renishaw Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 EMOTIV
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 BioXtreme Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms